Literature DB >> 11078620

False negative sentinel node procedure established through palpation of the biopsy wound.

P J Tanis1, O E Nieweg, J W Merkus, J L Peterse, B B Kroon.   

Abstract

We describe our first false negative sentinel node biopsy after ceasing confirmatory axillary lymph node dissection in breast cancer. Palpation of the axilla through the biopsy wound prevented understaging. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh：

Year:  2000        PMID： 11078620     DOI： 10.1053/ejso.2000.0987

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN： 0748-7983            Impact factor:   4.424


  5 in total

1.  Intraoperative identification of suspicious palpable lymph nodes as an integral part of sentinel node biopsy in patients with breast cancer.

Authors:  Young Jin Choi; Jung Han Kim; Seok Jin Nam; Young Hyeh Ko; Jung-Hyun Yang
Journal:  Surg Today       Date:  2008-04-30       Impact factor: 2.549

2.  Impact of patient- and disease-specific factors on SLNB in breast cancer patients. Are current guidelines justified?

Authors:  A Bembenek; J Fischer; H Albrecht; E Kemnitz; S Gretschel; U Schneider; S Dresel; P M Schlag
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

3.  Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.

Authors:  Katherine E Posther; Linda M McCall; Peter W Blumencranz; William E Burak; Peter D Beitsch; Nora M Hansen; Monica Morrow; Lee G Wilke; James E Herndon; Kelly K Hunt; Armando E Giuliano
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

4.  Histologic evaluation of sentinel and non-sentinel axillary lymph nodes in breast cancer by multilevel sectioning and predictors of non-sentinel metastasis.

Authors:  Piyarat Jeeravongpanich; Tuenjai Chuangsuwanich; Chulaluk Komoltri; Adune Ratanawichitrasin
Journal:  Gland Surg       Date:  2014-02

5.  Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients.

Authors:  P J Tanis; O E Nieweg; R A Valdés Olmos; J L Peterse; E J Th Rutgers; C A Hoefnagel; B B R Kroon
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.